Recent advances in the genomics and therapy of BCR/ABL1 -positive and -negative chronic myeloproliferative neoplasms-Reference-Cited by-同舟云学术

Recent advances in the genomics and therapy of BCR/ABL1 -positive and -negative chronic myeloproliferative neoplasms

Published:2018-04 Issue: Volume:67 Page:67-74
ISSN:0145-2126
Container-title:Leukemia Research
language:en
Short-container-title:Leukemia Research

Author:

Mughal Tariq I.,Gotlib Jason,Mesa Ruben,Koschmieder Steffen,Khoury H. Jean,Cortes Jorge E.,Barbui Tiziano,Hehlmann Rüdiger,Mauro Michael,Saussele Susanne,Radich Jerald P.,Van Etten Richard A.,Saglio Giuseppe,Verstovek Srdnan,Gale Robert Peter,Abdel-Wahab Omar

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference101 articles.

1. Long-term outcomes of imatinib treatment for chronic myeloid leukemia;Hochhaus;N. Engl. J. Med.,2017

2. Chronic myeloid leukemia: reminiscences and dreams;Mughal;Haematologica,2016

3. JAK2 inhibitors for myeloproliferative neoplasms: what is next;Bose;Blood,2017

4. A molecular roadmap for midostaurin in mastocytosis;Gotlib;Blood,2017

5. Myeloid neoplasms with eosinophilia;Reiter;Blood,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approach to Diagnosis of BCR::ABL1-Negative Myeloproliferative Neoplasms;Indian Journal of Medical and Paediatric Oncology;2023-11-27

2. Pharmacological Inhibition of Insulin Growth Factor-1 Receptor (IGF-1R) Alone or in Combination With Ruxolitinib Shows Therapeutic Efficacy in Preclinical Myeloproliferative Neoplasm Models;HemaSphere;2021-04-30

3. Interrogating the molecular genetics of chronic myeloproliferative malignancies for personalized management in 2021;Haematologica;2021-03-04

4. Frequency of coexistence and kinetics of the BCR-ABL1 transcript level and allele burden of JAK2V617F and CALR Type 1, 2 gene mutations in patients with chronic myeloid leukemia;Russian journal of hematology and transfusiology;2020-09-21

5. PDL1 blockage increases fetal resorption and Tfr cells but does not affect Tfh/Tfr ratio and B-cell maturation during allogeneic pregnancy;Cell Death & Disease;2020-02